Leukaemia is a cancer of blood-forming cells and is the most common group of childhood cancers. Symptoms can overlap with common illnesses, so diagnosis requires blood and bone-marrow evaluation. Treatment depends on the exact type, genetic features, risk group and response to therapy.
Most childhood leukaemia arises from acquired changes in developing blood cells, and parents did not cause it. Rare inherited conditions or previous treatments can increase risk, but most children have no identifiable risk factor.
Not what we wish you'd ask. What you're actually thinking when you find this page.
Book a consultationBlood tests may strongly suggest it, but bone-marrow and specialised tests usually confirm type and guide treatment.
Many childhood leukaemias respond well to modern treatment, but prognosis depends on type, biology, response and individual factors.
Duration varies by leukaemia type and protocol and may extend over months or years.
Many planned chemotherapy and supportive-care visits can occur in day care, while some phases or complications require hospital admission.
It can help confirm diagnosis, pathology, risk classification, treatment protocol and the most appropriate site of care.
Speak with Paediatric Haemato-Oncology or contact our team to organise the right starting point.